Multiple Australian outlets report on a shared analysis of regulatory records concerning a defibrillator device used in medical settings. The articles describe alleged safety problems with the unit, including sparking and burning during use, and a reported delay in operation of about 50 seconds. According to the reporting, the device had been promoted as a homegrown innovation, but the analysis argues that gaps or weaknesses in Australia’s medical device regulatory framework contributed to the flawed product being provided to users in Australia. The outlets say the analysis is based on examination of regulatory reports and compliance information, aiming to show how the approval or clearance pathways may not have prevented the device’s defects from reaching the market. The reporting presents the concerns as stemming from the regulatory process rather than from any single incident, focusing on what the authors describe as a “loophole” within the rules governing medical devices. The articles collectively highlight timing and performance issues associated with the device’s operation alongside the alleged physical safety risks.